BARNES GROUP INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • February 21st, 2017 • Barnes Group Inc • Miscellaneous fabricated metal products • Delaware
Contract Type FiledFebruary 21st, 2017 Company Industry JurisdictionThis Agreement, made and entered into this day of 20 (“Agreement”), by and between Barnes Group Inc., a Delaware corporation (“Corporation”), and (“Indemnitee”):
BARNES GROUP INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • August 2nd, 2010 • Barnes Group Inc • Miscellaneous fabricated metal products • Delaware
Contract Type FiledAugust 2nd, 2010 Company Industry JurisdictionThis Agreement, made and entered into this day of 20 (“Agreement”), by and between Barnes Group Inc., a Delaware corporation (“Corporation”), and (“Indemnitee”):
IMMUCELL CORPORATION INDEMNIFICATION AGREEMENTIndemnification Agreement • March 28th, 2007 • Immucell Corp /De/ • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledMarch 28th, 2007 Company Industry JurisdictionTHIS AGREEMENT is made and entered between ImmuCell Corporation, a Delaware corporation (the “Corporation”, which term shall include any one or more of its subsidiaries where appropriate), and the above-named director (“Indemnitee”), and shall be effective from and after the Effective Date set forth above.
ALLIED NEVADA GOLD CORP. INDEMNIFICATION AGREEMENTIndemnification Agreement • February 20th, 2007 • Allied Nevada Gold Corp • Gold and silver ores • Delaware
Contract Type FiledFebruary 20th, 2007 Company Industry JurisdictionThis INDEMNIFICATION AGREEMENT, to be effective as of the day of (“Agreement”), by and between Allied Nevada Gold Corp., a Delaware corporation (the “Corporation”), and (“Indemnitee”):
INDEMNIFICATION AGREEMENTIndemnification Agreement • December 14th, 2005 • Indevus Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 14th, 2005 Company Industry JurisdictionThis INDEMNIFICATION AGREEMENT, made and entered into as of the day of , 20 (“Agreement”), by and between Indevus Pharmaceuticals, Inc., a Delaware corporation (the “Corporation”), and (“Indemnitee”):